HB1192 Exempting certain household pharmaceutical wastes from the definition of hazardous waste.
Exempting certain household pharmaceutical wastes from the definition of hazardous waste.
Impact Score — How Does This Bill Affect You?
Overall Impact Score
Concerning
Scale: 1 (harmful) to 10 (beneficial)
Your Wallet
No direct financial impact to taxpayers or household budgets is evident from the text, which only modifies regulatory definitions.
Your Community
The bill does not specify changes to local services, infrastructure, or community programs.
Your Freedom
The bill is a technical regulatory amendment that does not explicitly expand or restrict individual rights or local control.
Status
Signed by Governor Ayotte 06/05/2026; Chapter 120; eff.08/04/2026
Sponsor
Linda Haskins (D)
The Short Version
This bill exempts household pharmaceutical wastes collected under RSA 318-E from the definition of hazardous waste in New Hampshire's waste management regulations. The practical impact depends on what RSA 318-E's collection program entails and whether this exemption affects how residents can dispose of old medications or changes regulatory oversight of those disposal methods.
Who's Behind This Bill?
Who Benefits
- ▲ Households disposing of pharmaceutical waste under the RSA 318-E program (if this exemption reduces their compliance burden)
- ▲ Entities administering pharmaceutical waste collection programs (if this reduces their regulatory compliance costs)
Who Pays the Price
- ▼ Potentially residents if the exemption reduces environmental or safety oversight of household pharmaceutical disposal pathways
- ▼ Potentially the Department of Environmental Services if oversight and monitoring costs shift without clear authority
Bill statuses as of October 7, 2026. Check LegiScan or NH General Court for the latest.
This bill was auto-scored using AI analysis of the bill text and legislative data. Scores may be refined as we review more bills.